|

Dapagliflozin 10mg Tab Clinical Trials

10 actively recruiting trials across 3 locations

Also known as: DAPA, Dapablix 10 mg, Farxiga, Forxiga, active drug, forxiga 10mg

Other7 trials

Cardiotoxicity in Breast Cancer Patients
Phase 4
Clinical Investigation of the Cardioprotective Effect of Early Administration of SGLT2 in Patients Presented With AMI
N/A
Dapagliflozin in STEMI
Phase 3
Potential Protective Role of SGLT-2 Inhibitors for Chemotherapy-induced Cardiotoxicity
Phase 2
SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative AF
Phase 3
SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease
Phase 2
SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus
Phase 4

Aurora, Colorado1 trial

Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients

University of Colorado Anschutz Medical Campus

Phase 4

Oklahoma City, Oklahoma1 trial

Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)

University of Oklahoma Health Sciences Center

Phase 3

Charlottesville, Virginia1 trial

Effect of Dapagliflozin on Microvascular Function in Women With Symptoms of Coronary Artery Disease

University of Virginia

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.